MedPath

云南永安制药有限公司

Ownership
-
Established
1990-08-10
Employees
-
Market Cap
-
Website
www.ynyazy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

68

NMPA:68

Drug Approvals

Roxithromycin Capsules

Product Name
罗红霉素胶囊
Approval Number
国药准字H20093883
Approval Date
Jun 14, 2024
NMPA

秋泻灵颗粒

Approval Number
国药准字Z20080251
Approval Date
Jul 24, 2023
NMPA

半枝莲胶囊

Approval Number
国药准字Z20080222
Approval Date
Jul 24, 2023
NMPA

心达康咀嚼片

Approval Number
国药准字Z20080615
Approval Date
Jul 24, 2023
NMPA

乌金片

Approval Number
国药准字Z20083008
Approval Date
Nov 3, 2022
NMPA

乌金胶囊

Approval Number
国药准字Z20080106
Approval Date
Nov 3, 2022
NMPA

Tranexamic Acid Injecton

Product Name
氨甲环酸注射液
Approval Number
国药准字H20065837
Approval Date
May 11, 2021
NMPA

Tranexamic Acid Injecton

Product Name
氨甲环酸注射液
Approval Number
国药准字H20065839
Approval Date
May 10, 2021
NMPA

Tranexamic Acid Injecton

Product Name
氨甲环酸注射液
Approval Number
国药准字H20065838
Approval Date
May 10, 2021
NMPA

小儿麻甘颗粒

Approval Number
国药准字Z20063553
Approval Date
Mar 31, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.